USD 0.04
(-1.76%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 135.05 Thousand USD | 236.24% |
2022 | 40.16 Thousand USD | 154.53% |
2021 | -73.66 Thousand USD | -425.53% |
2020 | 22.62 Thousand USD | 103.78% |
2019 | -598.1 Thousand USD | -4128.99% |
2018 | 14.84 Thousand USD | 103.93% |
2017 | -378.04 Thousand USD | -94.47% |
2016 | -194.39 Thousand USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 11.57 Thousand USD | 11.16% |
2023 Q4 | 10.41 Thousand USD | -62.21% |
2023 Q3 | 27.56 Thousand USD | 149.34% |
2023 Q1 | 86.02 Thousand USD | 2617.09% |
2023 Q2 | 11.05 Thousand USD | -87.15% |
2023 FY | 135.05 Thousand USD | 236.24% |
2022 Q2 | 4720.00 USD | -92.19% |
2022 FY | 40.16 Thousand USD | 154.53% |
2022 Q4 | 3166.00 USD | 111.25% |
2022 Q3 | -28.13 Thousand USD | -696.06% |
2022 Q1 | 60.41 Thousand USD | 166.5% |
2021 Q3 | 2984.00 USD | -75.58% |
2021 Q1 | 1981.00 USD | -31.95% |
2021 Q2 | 12.21 Thousand USD | 516.76% |
2021 Q4 | -90.84 Thousand USD | -3144.5% |
2021 FY | -73.66 Thousand USD | -425.53% |
2020 FY | 22.62 Thousand USD | 103.78% |
2020 Q4 | 2911.00 USD | 0.0% |
2019 FY | -598.1 Thousand USD | -4128.99% |
2018 FY | 14.84 Thousand USD | 103.93% |
2017 Q4 | 4.49 USD | 0.0% |
2017 FY | -378.04 Thousand USD | -94.47% |
2016 FY | -194.39 Thousand USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
American Medical Technologies Inc. | 1.69 Million USD | 92.051% |
Ansell Limited | 624.8 Million USD | 99.978% |
Ansell Limited | 624.8 Million USD | 99.978% |
BG Medicine, Inc. | - USD | -Infinity% |
Biotage AB (publ) | 113.94 Million USD | 99.881% |
BioLife Sciences Inc. | - USD | -Infinity% |
Psykey, Inc. | 415.97 Thousand USD | 67.533% |
ConvaTec Group Plc | 1.2 Billion USD | 99.989% |
ConvaTec Group Plc | 1.17 Billion USD | 99.989% |
Encision Inc. | 3.13 Million USD | 95.693% |
Golden Valley Development, Inc | - USD | -Infinity% |
Hear AtLast Holdings, Inc. | - USD | -Infinity% |
Innovative MedTech Inc. | 794.01 Thousand USD | 82.991% |
LifePoint, Inc. | -71.35 Thousand USD | 289.264% |
Medite Cancer Diagnostics, Inc. | -131 Thousand USD | 203.095% |
Paradigm Medical Industries, Inc. | 525 Thousand USD | 74.275% |
QuantRx Biomedical Corporation | - USD | -Infinity% |
Remedent, Inc. | 603.24 Thousand USD | 77.612% |
Reflect Scientific, Inc. | 596.42 Thousand USD | 77.356% |
SmileDirectClub, Inc. | 275.84 Million USD | 99.951% |
Sector 10, Inc. | - USD | -Infinity% |
Shandong Weigao Group Medical Polymer Company Limited | 900.72 Million USD | 99.985% |
SheerVision, Inc. | 2.17 Million USD | 93.793% |
United Health Products, Inc. | -4857.00 USD | 2880.626% |
Vasamed, Inc. | -69.38 Thousand USD | 294.637% |
Wearable Health Solutions, Inc. | 267.66 Thousand USD | 49.543% |
Yubo International Biotech Limited | 52.65 Thousand USD | -156.505% |